Toxicity evaluation to mice of phylloseptin-1, an antimicrobial peptide from the skin secretion of Phyllomedusa hypochondrialis (amphibia)

International Journal of Peptide Research and Therapeutics

Volumn 13, Issue 3, 2007, Pages 423-429

  Kückelhaus, Selma ^a   Leite, José Roberto S A ^b,c   Neves, Mateus P ^a   Frota, Karla S ^a   Abdala, Lídia F ^d   Muniz Junqueira, Maria Imaculada ^a   Bloch Jr , Carlos ^c   Tosta, Carlos Eduardo ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

^c EMBRAPA RECURSOS GENÉTICOS E BIOTECNOLOGIA   (Brazil)

^d Instituto e Laboratório Sabin de Análises Clínicas   (Brazil)

Author keywords

Antimicrobial peptide; Cytotoxicity; Genotoxicity; Mouse; Phyllomedusa hypochondrialis; Phylloseptin 1

Indexed keywords

CYCLOPHOSPHAMIDE; PHYLLOSEPTIN 1; POLYPEPTIDE ANTIBIOTIC AGENT; UNCLASSIFIED DRUG;

AMPHIBIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG SYNTHESIS; ERYTHROCYTE; FEMALE; GENOTOXICITY; HISTOLOGY; IN VIVO STUDY; KIDNEY; LIVER; LUNG; MOUSE; MOUSE STRAIN; NONHUMAN; PHYLLOMEDUSA HYPOCHONDRIALIS; SKIN SECRETION; SPLEEN; SWISS WEBSTER MOUSE;

AMPHIBIA; MUS; NEGIBACTERIA; PHYLLOMEDUSA HYPOCHONDRIALIS; POSIBACTERIA;

EID: 36649026382     PISSN: 15733149     EISSN: 15733904     Source Type: Journal    
DOI: 10.1007/s10989-006-9060-1     Document Type: Article

References (36)

1. Ambroggio E. E., Separovic F., Bowie J. H., Fidelio G. D., Bagatolli L. A. (2005) Biophys. J. 89:1874-1881
2. Andrès E., Dimarcq J. L. (2004) Rev. Med. Interne 25:629-635
3. Apponyi M. A., Pukala T. L., Brinkworth C. S., Maselli V. M., Bowie J. H., Tyler M. J., Booker G. W., Wallace J. C., Carver J. A., Separovic F., Doyle J., Llewellyn L. E. (2004) Peptides 25:1035-1054
4. Black M. T., Hodgson J. (2005) Adv. Drug Deliv. Rev. 57:1528-1538
5. Blondelle S. E., Houghten R. A. (1991) Biochemistry 30:4671-4678
6. Brand G. D., Leite J. R. S. A., Silva L. P., Albuquerque S., Prates M. V., Azevedo R. B., Carregaro V., Silva J. S., Sá V. C. L., Brandão R. A., Bloch Jr. C. (2002) J. Biol. Chem. 277:49332-49340
7. Bolliger A. P. (2004) Vet. Clin. Pathol. 33:58-67
8. Brillard J. P., Mcdaniel G. R. (1985) Poult. Sci. 64:155-158
9. Chen T., Farragher S., Bjourson A. J., Orr D. F., Rao P., Shaw C. (2003) Biochem. J. 371:125-130
10. Chen T., Xue Y., Zhou M., Shaw C. (2005) Peptides 26:377-383
11. Clark, G.: 1980, Stained Procedures, 4th ed., Williams & Wilkins, Baltimore, London
12. Colvin, M. and Chabner, B. A.: 1990, in: Chabner, B. A., Collins, J. M. (eds.), Cancer Chemotherapy: Principles and Practices, J.B. Lippencott, Philadelphia, California, pp. 276-313
13. Cunha Filho G. A., Schwartz C. A., Resck I. S., Murta M. M., Lemos S. S., Castro M. S., Kyaw C., Pires Jr. O. R., Leite J. R. S. A., Bloch Jr. C., Schwartz E. F. (2005) Toxicon 45:777-782
14. Evans H. J. (1997) Mutat. Res. 392:5-10
15. Glantz S. A. (1992). Primer of Biostatistics. McGraw Hill, New York
16. Goluszko P., Nowicki B. (2005) Infect. Immun. 73:7791-7796
17. Hancock R. E. W., Diamond G. (2000) Trends Microbiol. 8:402-410
18. Krugliak M., Feder R., Vadim Y., Zolotarev L. G., Dagan A., Ginsburg H., Mor A. (2000) Antimicrob. Agents Chemother. 44:2442-2451
19. Leite J. R. S. A., Silva L. P., Rodrigues M. I. S., Prates M. V., Brand G. D., Lacava B. M., Azevedo R. B., Bocca A. L., Albuquerquee S., Bloch Jr. C. (2005) Peptides 26:565-573
20. Merrifield R. B. J. (1963) Chem. Soc. 85:2149-2156
21. Matsuzaki K. (1999) Biochim. Biophys. Acta 1462:1-10
22. Mor A., Nguyen V. H., Delfour A., Migliore S. D., Nicolas P. (1991) Biochemistry 30:8824-8830
23. Moura, R. A. A. (ed.): 1982, in Técnicas de Laboratório, Ed. Atheneu, Rio de Janeiro, RJ, pp. 77-119
24. Ownby C. L., Powell J. R., Jiang M. S., Fletcher J. E. (1997) Toxicon 35:67-80
25. Peschel A. (2002) Trends Microbiol. 10:179-186
26. Rabelo-Gay, M. N.: 1991, in: Rabelo-Gay, M. N., Rodrigues, M. A. L. R., Monteleone-Neto, R. (eds.), Mutagênese, teratogênese e carcinogênese: métodos e critérios de avaliaçã o, Sociedade Brasileira de Genética, Ribeirão Preto, São Paulo, pp. 83-90
27. Schmid W. (1975) Mutat. Res. 31:9-15
28. Silva L. P. (2004) Lett. Drug Design Discov. 3:230-236
29. Sitaram N., Nagaraj R. (1999) Biochim. Biophys. Acta 1462:29-54
30. Shiri J., Navon-Venezia S., Feder R., Gaidukov L., Carmeli Y., Mor A. (2002) Antimicrob. Agents Chemother. 46:689-694
31. Stark M., Liu L. P., Deber C. M. (2002) Antimicrob. Agents Chemother. 46:3585-3590
32. Steiner H., Hultmark D., Engstrom A., Bennich H., Boman H. G. (1981) Nature 292:246-248
33. Tomasinsig L., Skerlavaj B., Papo N., Giabbai B., Shai Y., Zanetti M. (2006) J. Biol. Chem. 281:383-391
34. Vanhoye D., Bruston F., Nicolas P., Amiche M. (2003) Eur. J. Biochem. 270:2068-2081
35. World Health Organization: 2000, Drug resistance threatens to reverse medical progress, Press Release WHO/41.12
36. World Health Organization: 2001, Good Laboratory Practice (GLP) UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (document no. TDR/PRD/GLP/01.1B)